DEC2-SCN2A轴通过调节神经元可塑性,对大麻素的抗效果至关重要
Huifang Song1, Yifan Wang1, Lili Wang1
1State Key Laboratory of Natural and Biomimetic Drugs, Department of Molecular and Cellular Pharmacology, School of Pharmaceutical Sciences, Peking University, Beijing, 100191, China.
Advanced science (Weinheim, Baden-Wurttemberg, Germany)
|July 11, 2025
概括
转录因子DEC2通过控制SCN2A表达来调节神经元可塑性和. 大麻 (CBD) 增强了这种效果,这表明了治疗的新治疗标.
科学领域:
- 神经科学是一个神经科学.
- 分子生物学分子生物学
- 遗传学 遗传学 是一个
背景情况:
- 神经元可塑性受损与等神经系统疾病有关.
- 控制神经元可塑性和的精确调节机制尚不清楚.
研究的目的:
- 调查转录因子DEC2在调节神经元可塑性和发作的作用.
- 阐明DEC2影响神经元刺激性和突触传播的分子机制.
- 探索针对治疗的DEC2-SCN2A通路的潜力.
主要方法:
- 在海马神经元中利用了DEC2的淘汰和过度表达.
- 通过促进体结合试验,研究了DEC2对SCN2A的转录调节.
- 研究了大麻二醇 (CBD) 对DEC2-SCN2A轴的影响.
主要成果:
- 降低DEC2增加了神经元刺激性和发作易感性.
- DEC2过度表达降低了神经元刺激性和发作易感性.
- DEC2通过与其促进体结合,直接抑制SCN2A转录.
- CBD增强了DEC2对SCN2A的抑制作用.
结论:
- DEC2是神经元可塑性和发作的关键调节者.
- DEC2-SCN2A通路代表了的新型治疗标.
- CBD通过DEC2-SCN2A轴调节的进展.
相关概念视频
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
456
Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
456
Antiepileptic Drugs: GABAergic Pathway Potentiators
665
γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
665
Chemotherapy-Induced Nausea and Vomiting: Cannabinoids
371
Tetrahydrocannabinol (THC) is a phytocannabinoid that primarily interacts with the CB1 receptor, a type of G protein-coupled receptor (GPCR) predominantly in and around the chemoreceptor trigger zone (CTZ) and emetic center. THC also blocks the serotonin receptor activity in the dorsal vagal complex (DVC) by inhibiting serotonin release. THC exerts its anti-emetic effects through these interactions, which are beneficial for patients undergoing chemotherapy.
Two synthetic agonists of THC,...
Two synthetic agonists of THC,...
371
Antiepileptic Drugs: Calcium Channel Blockers
640
Calcium channel blockers, a class of antiepileptic drugs, regulate the flow of calcium ions within neurons.
Calcium channel blockers exert their antiepileptic effects by targeting T-type calcium channels, which are integral to transmitting nerve signals in the central nervous system. These channels allow the passage of calcium ions, which are vital for neuronal communication. By inhibiting T-type calcium channels, calcium channel blockers effectively reduce the release of neurotransmitters and...
Calcium channel blockers exert their antiepileptic effects by targeting T-type calcium channels, which are integral to transmitting nerve signals in the central nervous system. These channels allow the passage of calcium ions, which are vital for neuronal communication. By inhibiting T-type calcium channels, calcium channel blockers effectively reduce the release of neurotransmitters and...
640
Antiepileptic Drugs: Glutamate Antagonists
523
Glutamate is a fundamental neurotransmitter in the central nervous system, playing a vital role in neuronal communication and various cognitive processes. Glutamate stands as the principal excitatory neurotransmitter in the brain. Its presence is crucial for the communication between neurons, underpinning essential processes such as synaptic transmission, neuronal excitability, and plasticity. These functions are vital for higher-order cognitive processes, including learning and memory. The...
523
Antiepileptic Drugs: Potassium Channel Activators
283
Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
Ezogabine has gained approval as an adjunctive treatment...
283


